Edwards Lifesciences Corp (NYSE:EW)

CAPS Rating: 3 out of 5

A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies.

Recs

0
Player Avatar ROEoutshinesGOLD (98.60) Submitted: 4/24/2013 10:21:31 AM : Outperform Start Price: $82.21 EW Score: -22.06

"The Gory Details on Edwards Lifesciences's Double Miss" :

fool.com/investing/general/2013/04/24/the-gory-details-on-edwards-lifesciencess-double-.aspx

Featured Broker Partners


Advertisement